Tyrosine Kinase Inhibitor-Related Hepatotoxicity in Patients with Advanced Lung Adenocarcinoma: A Real-World Retrospective Study

Jie Qian,1,2,* Xueyan Zhang,2,* Bo Zhang,2 Bo Yan,2 Lin Wang,3 Ping Gu,2 Weimin Wang,2 Huimin Wang,2 Baohui Han2 1Department of Emergency Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; 2Department of Pulmonary Medicine, Shanghai Chest Ho...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Qian J, Zhang X, Zhang B, Yan B, Wang L, Gu P, Wang W, Wang H, Han B
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2020-05-01
coleção:	Cancer Management and Research
Assuntos:	lung adenocarcinoma hepatotoxicity tyrosine kinase inhibitor gefitinib erlotinib icotinib
Acesso em linha:	https://www.dovepress.com/tyrosine-kinase-inhibitor-related-hepatotoxicity-in-patients-with-adva-peer-reviewed-article-CMAR
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!